COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly variable disease severity and a bimodal course characterized by acute respiratory viral infection followed by hyperinflammation in a subset of patients with severe disease. This immune dysregulation is characterized b...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Jason D, Robinson, Philip C, Uldrick, Thomas S, Ljungman, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206176/
https://www.ncbi.nlm.nih.gov/pubmed/34117116
http://dx.doi.org/10.1136/jitc-2021-002630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206176/
https://www.ncbi.nlm.nih.gov/pubmed/34117116
http://dx.doi.org/10.1136/jitc-2021-002630

Ejemplares similares